Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2011 Dec;63(12):1664–1671. doi: 10.1002/acr.20617

Table 5.

Phase 3: Assessment of Construct Validity: Correlations between S-VLA Scores and Other Measures

Correlation of S-VLA with:

HAQ RADAI SAWS
Total
SAWS
Abilities
APaQ SF-36
PCS
SF-36
Physical
Functioning
SF-36
Role
Physical
SF-36
Social
Functioning
Total sample 0.81 0.71 0.81 0.82 0.65 −0.78 −0.80 −0.67 −0.72
By sex
Women (n = 111) 0.81 0.67 0.89 0.82 0.65 −0.77 −0.79 −0.68 −0.74
Men (n = 39) 0.78 0.82 0.83 0.82 0.65 −0.78 −0.82 −0.60 −0.71
By RA duration
<25 months (n = 18) 0.81 0.69 0.82 0.84 0.84 −0.89 −0.94 −0.67 −0.81
≥ 25 months (n = 132) 0.81 0.72 0.81 0.82 0.65 −0.76 −0.78 −0.68 −0.75

RADAI = Rheumatoid Arthritis Disease Activity Index; HAQ = Health Assessment Questionnaire; SAWS = Satisfaction with Abilities and Well-being Scale; APaQ = Activity Participation Questionnaire; SF-36 = Short-Form-36 Health Survey

Note: For the S-VLA, HAQ, RADAI, SAWS, and APaQ, higher scores reflect worse functioning. For the SF-36 scales, higher scores reflect better functioning